Ahmed Mehdi
Biostatician
Biomedical Sciences
Translational Research Institute
Australia
Biography
Dr. Ahmed Mehdi completed his PhD from Institute for Molecular Bioscience, the University of Queensland, Australia. His major interests are in Biostatistics, Proteomics, Genomics and Immunoinformatics.
Research Interest
Bioinformatics, Biostatistics, Computational Immunology
Publications
-
*Mehdi A, *Benham H, *Nel H, *Law S, Street S, Namnoruth N, Pahau H, Lee B, Ng J, Brunck M, Hyde C, Trouw L, Dudek N, Purcell A, O'Sullivan B, Connolly J, Paul S, Cao KA, Thomas R (2015) “Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patientsâ€, Sci. Transl. Med. 7 (290): 1-11.
-
Pang D, Irvine K, Mehdi A, Thomas H, Harris M, Hamilton-Williams and Thomas R (2015) “Expression profiling pre-diabetic mice to uncover drugs with clinical application to type 1 diabetes", Clinic. Transl. Imm. 4 (e41): 1-11.
-
Garcia-Gonzalez, P, Schinnerling K, Sepulveda-Gutierrez A, Maggi J, Hoyos L, Morales R, Mehdi A, Nel H, Soto L, Pesce B, Carmen M, Maria Cuchacovich, Miguel, Larrondo, Milton L., Neira, Oscar, Francisco Catalan, Diego, Hilkens, Molina M, Cuchacovich, M, Larrondo M, Neira O, Catalan D, Hilkens C, Thomas R, Verdugo R and Aguillon, J (2016) “Treatment with dexamethasone and monophosphoryl lipid a removes disease-associated transcriptional signatures in monocyte-derived dendritic cells from rheumatoid arthritis patients and confers tolerogenic featuresâ€, Frontiers in Immunology. 7 (43): 1-11.
